Sorafenib inhibits ovarian cancer cell proliferation and mobility and induces radiosensitivity by targeting the tumor cell epithelial–mesenchymal transition
Chuntao Tian(Xian Central Hospital), Shunchang Jiao(Chinese PLA General Hospital)
Cited by 8
Related Papers
Methylation of NRN1 is a novel synthetic lethal marker of PI3K‐Akt‐mTOR and ATR inhibitors in esophageal cancer
|Cancer Science|2021|34
A nomogram‑based immunoprofile predicts clinical outcomes for stage II and III human colorectal cancer
|Molecular and Clinical Oncology|2021|23